NL
APYX icon

NWAM LLC’s Apyx Medical APYX Stock Holding History

NWAM LLC’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Buy
17,239
+4,467
+35% +$17.7K ﹤0.01% 678
2026
Q1 		$47.1K Buy
+12,772
New +$47.7K ﹤0.01% 615

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NWAM LLC's APYX Position: Q2 2026 in Review

NWAM LLC increased its Apyx Medical (APYX) stake by 35% in Q2 2026, buying an estimated $17.7K and bringing the position to 17,239 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

NWAM LLC first reported a position in APYX in Q1 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • NWAM LLC held 17,239 shares of Apyx Medical worth $77.4K as of Q2 2026.
  • NWAM LLC bought 4,467 Apyx Medical shares in Q2 2026, an estimated $17.7K.
  • Apyx Medical made up ﹤0.01% of NWAM LLC's portfolio in Q2 2026, its #678 holding.
  • NWAM LLC first reported a position in Apyx Medical in Q1 2026 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.